Svelte Medical Systems Receives FDA Approval For SLENDER IDS

World's Lowest Profile Drug-Eluting Stent Systems with the Lowest Rate of 1 Year Reintervention Reported in a U.S. Pivotal Study Now Approved for Use in U.S. Patients Svelte Medical Systems received

Related Keywords

New Providence , New Jersey , United States , North Carolina , Ohio State University , Ohio , Christ Hospital , Cincinnati , Jack Darby , Kostenloser Wertpapierhandel , Sunil Rao , Christ Hospital Heart Vascular Institute , Drug Administration , Svelte Medical Systems Inc , Lowest Profile Drug Eluting Stent Systems , Lowest Rate , Reintervention Reported , Study Now Approved , Medical Systems , Target Lesion Revascularization , Device Exemption , Dean Kereiakes , Clinical Professor , Duke University , Svelte Medical , Svelte Medical Systems , Svelte , Medical , Systems , Eceives , Approval , Blender , Direct , Bioresorbable , Ncoated , Drug , Eluting , Tent ,